ATYR ATYR PHARMA INC revenue, earnings and financials
For the quarter ended June 30, 2026, ATYR PHARMA INC reported revenue of n/a, net income of −$10.3M and diluted EPS of −$0.11; for the fiscal year ended December 2025 revenue was $190K, down 19.1% on the year before.
ATYR annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $190K, gross profit n/a, operating income −$77.6M, net income −$74.1M (margin -39009.5%), EPS −$0.80
- Fiscal year ended Dec 2024: revenue $235K, gross profit n/a, operating income −$67.9M, net income −$64.0M (margin -27243.8%), EPS −$0.86
- Fiscal year ended Dec 2023: revenue $353K, gross profit n/a, operating income −$54.9M, net income −$50.4M (margin -14274.5%), EPS −$0.94
- Fiscal year ended Dec 2022: revenue $10.4M, gross profit n/a, operating income −$46.4M, net income −$45.3M (margin -436.5%), EPS −$1.60
- Fiscal year ended Dec 2021: revenue $0, gross profit n/a, operating income −$34.0M, net income −$33.8M (margin n/a), EPS −$1.77
ATYR quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$10.3M, EPS −$0.11
- Quarter ended Mar 31, 2026: revenue n/a, net income −$10.8M, EPS −$0.11
- Quarter ended Dec 31, 2025 (from the annual report): revenue $0, net income −$14.0M, EPS −$0.15
- Quarter ended Sep 30, 2025: revenue $190K, net income −$25.7M, EPS −$0.26
- Quarter ended Jun 30, 2025: revenue $0, net income −$19.5M, EPS −$0.22
- Quarter ended Mar 31, 2025: revenue $0 (down 100.0% year over year), net income −$14.9M, EPS −$0.17
- Quarter ended Dec 31, 2024 (from the annual report): revenue $0, net income −$15.0M, EPS −$0.17
- Quarter ended Sep 30, 2024: revenue $0 (down 100.0% year over year), net income −$17.3M, EPS −$0.23
- Quarter ended Jun 30, 2024: revenue $0, net income −$16.3M, EPS −$0.23
- Quarter ended Mar 31, 2024: revenue $235K, net income −$15.5M, EPS −$0.23
- Quarter ended Dec 31, 2023 (from the annual report): revenue $0, net income −$14.8M, EPS −$0.23
- Quarter ended Sep 30, 2023: revenue $353K, net income −$11.3M, EPS −$0.20
- Quarter ended Jun 30, 2023: revenue $0, net income −$12.3M, EPS −$0.22
- Quarter ended Mar 31, 2023: revenue $0, net income −$12.0M, EPS −$0.29
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$7.52M, EPS −$0.26
- Quarter ended Sep 30, 2022: revenue $0, net income −$13.2M, EPS −$0.46
- Quarter ended Jun 30, 2022: revenue n/a, net income −$12.4M, EPS −$0.44
- Quarter ended Mar 31, 2022: revenue n/a, net income −$12.2M, EPS −$0.44
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$8.56M, EPS −$0.20
- Quarter ended Sep 30, 2021: revenue n/a, net income −$7.67M, EPS −$0.42
ATYR cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$62.0M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$69.1M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$33.2M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$41.9M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$33.1M, share buybacks n/a
ATYR balance sheet
- Jun 30, 2026: cash $16.2M, total assets $69.8M, total liabilities n/a, shareholders' equity $48.8M
- Mar 31, 2026: cash $10.0M, total assets $79.7M, total liabilities n/a, shareholders' equity $57.9M
- Dec 31, 2025: cash $10.7M, total assets $93.0M, total liabilities n/a, shareholders' equity $67.5M
- Sep 30, 2025: cash $6.15M, total assets $107M, total liabilities n/a, shareholders' equity $80.2M
- Jun 30, 2025: cash $17.2M, total assets $102M, total liabilities n/a, shareholders' equity $74.8M
- Mar 31, 2025: cash $10.4M, total assets $97.2M, total liabilities n/a, shareholders' equity $75.1M
- Dec 31, 2024: cash $11.1M, total assets $96.8M, total liabilities n/a, shareholders' equity $70.0M
- Sep 30, 2024: cash $11.5M, total assets $91.6M, total liabilities n/a, shareholders' equity $65.3M
What is ATYR's revenue?
ATYR PHARMA INC reported $190K of revenue for the fiscal year ended December 2025.
Is ATYR profitable?
No. ATYR PHARMA INC lost $60.8M over the last four quarters.
What is ATYR's EPS?
Diluted earnings per share over the last four quarters were −$0.63; −$0.11 in the latest quarter.